Eli Lilly and Co has announced that it will buy privately held Versanis for potentially up to $1.93bn to strengthen its position in the fast-growing
A smartphone-based app designed to deliver cognitive-behavioral therapy (CBT) to adults with Type 2 diabetes has received marketing approval as a class II medical device from the
It’s an ongoing debate in the diabetes world: is it ideal to consume a very low carbohydrate diet, or better to go with moderate amounts
The U.S. Food and Drug Administration (FDA) has now approved Lantidra, the first allogeneic (donor) pancreatic islet cellular therapy made from deceased donor pancreatic cells for
The FDA has approved the Lantidra allogeneic pancreatic islet cellular therapy developed by CellTrans to treat diabetes. This is the first approval of a donor
Beta Bionics has raised private funding of $100m to support commercialization and further development of iLet Bionic Pancreas, its recently-authorized automated insulin dosing (AID) system, which
Abbott and Bigfoot Biomedical have announced a definitive agreement for Abbott to acquire Bigfoot, a leader in developing smart insulin management systems for people with diabetes.
New data suggests that significant reductions in HbA1c have occurred over time among adults with Type 1 diabetes as their use of diabetes technology has
The Association of Medical Research Charities (AMRC) is a membership organisation dedicated to supporting medical research charities in saving and improving lives through research and
A new study in the JAMA Network Open journal has found an unusual rise in the number of children and teenagers around the world diagnosed
